ESOPMay 5, 2026, 07:02 AM
BioCryst Grants 61,750 RSUs to 6 New Employees
AI Summary
BioCryst Pharmaceuticals announced that its compensation committee granted restricted stock units (RSUs) covering an aggregate of 61,750 shares of common stock to six newly-hired employees. These RSUs, granted on May 1, 2026, serve as material inducements for their employment. The grants vest in four equal annual installments, beginning on the one-year anniversary of the grant date, contingent on continued service, and comply with Nasdaq Listing Rule 5635(c)(4).
Key Highlights
- BioCryst granted restricted stock units (RSUs) to 6 newly-hired employees.
- RSUs cover an aggregate of 61,750 shares of BioCryst common stock.
- The grants were made as of May 1, 2026.
- RSUs vest in four equal annual installments.
- First vesting occurs on the one-year anniversary of the grant date.
- Grants comply with Nasdaq Listing Rule 5635(c)(4).
Price Impact
More from BCRX